- Presentations
- 3
- Markets
- 1
Janumet XR is a brand of Metformin and Sitagliptin marketed by Merck Sharp & Dohme, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Metformin and Sitagliptin
- Brand owner
- Merck Sharp & Dohme
- Registered in
- United States
- Strengths and forms
- 1000 mg/100 mg extended-release tablet, 1000 mg/50 mg extended-release tablet, 500 mg/50 mg extended-release tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Janumet XR 1000 mg/100 mg extended-release tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
| Janumet XR 1000 mg/50 mg extended-release tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
| Janumet XR 500 mg/50 mg extended-release tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
Equivalent brands
Other brands of Metformin and Sitagliptin.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Janumet XR
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.